background

background

NEWS

30 August 2023

Biotech behind promising Covid vaccine pivots to veterinary medicine, spins off two divisions

Biotech behind promising Covid vaccine pivots to veterinary medicine, spins off two divisions

28 August 2023

Weekly companion animal news August 28, 2023: Akston Biosciences turns focus to companion animal health

Weekly companion animal news August 28, 2023: Akston Biosciences turns focus to companion animal health

28 August 2023

Akston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City

Akston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City

18 August 2023

Akston Biosciences Corporation will focus on breakthrough protein therapeutics for Companion Animal Health

Akston Biosciences Corporation will focus on breakthrough protein therapeutics for Companion Animal Health

17 August 2023

Akston Biosciences to Focus on Strong Animal Health Pipeline

Akston Biosciences to Focus on Strong Animal Health Pipeline

16 August 2023

Akston Biosciences explores 2024 IPO while it raises up to USD 45m in equity round, CEO says

Akston Biosciences explores 2024 IPO while it raises up to USD 45m in equity round, CEO says

14 August 2023

Akston Biosciences to Focus on Strong Animal Health Pipeline

Akston Biosciences to Focus on Strong Animal Health Pipeline

8 March 2023

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

1 November 2022

Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial

Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial

7 September 2022

Akston starts small and likes it that way

Akston starts small and likes it that way

Previous

Dots

Next